EANS-News: Balda AG: Supervisory Board approves further steps for an acquisition in the Medical business division
Bad Oeynhausen (euro adhoc) -
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.
Company Information
13 December 2010 - The Supervisory Board of the Frankfurt Stock Exchange listed Balda AG, during its regular session on 10 December 2010 in Beijing, has confirmed the already initiated search for acquisition opportunities for the planned strategic expansion of Balda Medical.
A further issue on the agenda was the continued sluggish business development and the demanding conditions affecting the MobileCom business division. Call-offs continue to be unsatisfactory. Competition is still very intense and pressure on prices high. As already stated, the division is under constant critical review by the Board of Directors.
No decision was taken on the issue of a potential disposal of Balda shares held in TPK. The lock-up period for the first fifty per cent of the Balda stake in TPK closes at the end of April 2011. A decision will be made in due time before the end of the lock-up period. The Board of Directors and Supervisory Board will strive to achieve a decision that is in the interests of Balda shareholders.
* * *
Company Profile Balda AG The Balda Group develops and produces complete plastic assemblies, electronic products and products for the medical industry. The customers of Balda are leaders in business from the mobile, entertainment and electronic communications as well as pharmaceutical and medical technology markets. The group has an international position with product sites in China, Malaysia and Germany. A subsidiary in the United States serves North American customers in product design and development. As part of a shareholding in a leading manufacturer of touch screens in China, Balda participates in the dynamic touch screen displays market.
* * *
This corporate news announcement includes "forward-looking statements" which are based on the current expectations of the management of Balda. They are subject to risks and uncertainty because they relate to events and depend on circumstances that will occur in the future, such as, for example, developments in the mobile communications industry, changes in technology and the ability to timely and successfully develop new products and various other factors. Balda does not undertake any obligation to update publicly or revise forward-looking statements except to the extent legally required. This corporate news announcement is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States or elsewhere. The shares in Balda AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act") unless registered under the Securities Act or pursuant to an exemption from such registration. The Shares have not been and will not be registered under the Securities Act.
end of announcement euro adhoc
Further inquiry note:
Clas Röhl
Tel.: +49 (0) 5734 922-2728
croehl@balda.de
Branche: Semiconductors & active components
ISIN: DE0005215107
WKN: 521510
Index: CDAX, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade